. The most commonly used species of lactic acid bacteria in probiotic preparations (3) .
including genetic fingerprinting, gene sequencing, oligonucleotide probes and specific primer selection, discriminate closely related bacteria with varying degrees of success. Additional molecular methods being employed to determine the constituents of complex microbiota in this area of research are community analysis, denaturing gradient gel electrophoresis (DGGE)/temperature gradient gel electrophoresis (TGGE), fluorescent in situ hybridisation (FISH) and probe grids (4).
Cancer
Cancer is a serious global public health problem. There are several epidemiological evidences that support a protective role of probiotics against cancer. A wealth of data implicates that ErbB receptors have essential roles in tumor development. Probiotic bacteria are known to exert an anticancer activity in animal studies(5).
Lactic acid bacteria and their probioactive cellular substances exert many beneficial effects in the gastrointestinal tract, and also release various enzymes into the intestinal lumen and exert potential synergistic (LAB) effects on digestion and alleviate symptoms of intestinal malabsorption (6) . A carcinogen is any substance, radionuclide, or radiation that is an agent directly involved in causing cancer. This may be due to the ability to damage the genome or to the disruption of cellular metabolic processes.
Colon Cancer
Colon cancer is the second to third most frequent type of cancer in Western industrialized countries. fiber diet, are of greater interest because they represent controllable risk factors. Within the complex gut microflora, which consists of >1 1011 living bacteria/g colon content, LAB belong to those bacteria with such beneficial effects (7) investigated for possible use as probiotics and for colon cancer biological products. Five of these strains inhibited growth of eight food-borne pathogens including Helicobacter pylori, Escherichia coli and Salmonella typhimurium (8) . Figure 2 . Mechanism of action of probiotics during colon cancer progression (6) Several mechanisms have been proposed as to how LAB may inhibit colon cancer, including enhancing the host's immune response, altering the metabolic activity of the intestinal microbiota, binding and degrading carcinogens, producing antimutagenic compounds, and altering the physiochemical conditions in the colon (6) It appears that LAB can reduce the levels of colon enzymes that convert procarcinogens to carcinogens. Specifically, LAB can reduce levels of the enzymes β-glucuronides, nitroreductase, and azo-reductase (Kampmanet al. 1994).
Most animal and human studies do indicate that feeding certain LAB decreases fecal enzyme levels that may be involved in formation of carcinogens. Also, beneficial effects can be attributed to immunepotentiating effects by LAB strains. One specific effect was shown by heat-killed Lactobacillus plantarum L-137, which restored the inhibited IL-12 production in DBA/2 mice with tumors (9). The anti -tumor effects were found to be due to the activation of macrophage by LC9018 (10).
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Breast Cancer
Results of cross-cultural and regional correlation studies have shown that breast cancer mortality correlates positively with the consumption of milk products (11) . Milk fermented by B. infant is, B. bifidum, B. animalis, L. acidophilus and L. paracasei inhibited the growth of the MCF7 breast cancer cell line, and the antiproliferative effect was not related to the presence of bacteria (12) . Isoflavones are a class of phytoestrogens plant-derived compounds with estrogenic activity. Soybeans and soy products are the richest sources of isoflavones in the human diet (13) Soy phytoestrogens were suggested to reduce the risk of a number of diseases including breast cancer. Given that these compounds are metabolized by bacteria, alteration of intestinal bacteria and enzymes may affect phytoestrogen metabolism (14) . Observational studies suggest that dietary isoflavones reduce breast cancer risk, and this may be caused in part by effects on endogenous hormone concentrations. Because intestinal bacteria metabolize isoflavones, it was hypothesized that consumption of probiotic bacteria would enhance the biologic effects of isoflavones, including effects on endogenous hormones (15) .
Bladder Cancers
Few human clinical trials conducted, one showed that L. casei consumption (three times per day for 1 year) increased the recurrence free period among subjects with bladder cancer (16). Daily intake of a viable L. casei strain postponed recurrence of bladder tumors in a randomized, controlled, multicenter study in 48 Japanese patients. Patients were enrolled within 2 week after removal of one or more bladder tumors (17). One hypothesis for the prevention or delay of tumor development by lactobacilli is that they might bind to mutagenic compounds in the intestine (18) . Liver cancer: Liver cancer is the sixth most commonly diagnosed cancer in the world, and the third most common cause of death from cancer, according to Cancer Research UK (19) .
Probiotics have also been shown to attenuate hepatotoxic effects of aflatoxin, a well known liver carcinogen, in rats (20) and to reduce biomarkers of liver cancer risk in a human intervention trial (20) . probiotic bacteria could block the intestinal absorption of aflatoxin B1 and thereby lead to reduced urinary excretion of aflatoxin B1-N7-guanine (AFB-N7-guanine), a marker for a biologically effective dose of aflatoxin exposure. Elevated urinary excretion of this aflatoxin-DNA adduct is associated with an increased risk of liver cancer (19) .
Conclusion
The probiotic theory offers an intriguing approach to controlling negative metabolic or pathogenic activities of microbes to which we are exposed on a daily basis. results suggest that consumption of a high amount of fermented milk products may have a protective effect on the risk of cancer (3).
